S&P TSX Capped Composite...

US Dollar vs CAD

Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.

Get Started

ERNA Eterna Therapeutics Inc

0.2569

0.00 (0.00%)

Pre Market

Last Updated: 06:00:06

Delayed by 15 minutes

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]

Eterna Therapeutics (NASDAQ:ERNA)
Historical Stock Chart
From Feb 2025 to Mar 2025

Click Here for more Eterna Therapeutics Charts.

Eterna Therapeutics (NASDAQ:ERNA)
Historical Stock Chart
From Mar 2024 to Mar 2025

Click Here for more Eterna Therapeutics Charts.

Eterna Therapeutics Inc News

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Wednesday 12 March 2025 (5 days ago) • Edgar (US Regulatory)

Form 8-K - Current report
Wednesday 12 March 2025 (5 days ago) • Edgar (US Regulatory)

Form SCHEDULE 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
Wednesday 5 March 2025 (2 weeks ago) • Edgar (US Regulatory)

Eterna Therapeutics Hosts Successful Inaugural Meeting with Newly Formed Scientific Advisory Board to Advance Cell Therapy Pipeline
Wednesday 26 February 2025 (3 weeks ago) • GlobeNewswire Inc.

Form 8-K - Current report
Thursday 13 February 2025 (1 month ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Monday 10 February 2025 (1 month ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Monday 10 February 2025 (1 month ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Monday 10 February 2025 (1 month ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Monday 10 February 2025 (1 month ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Monday 10 February 2025 (1 month ago) • Edgar (US Regulatory)

Eterna Therapeutics Announces Expansion of Scientific Advisory Board
Tuesday 28 January 2025 (2 months ago) • GlobeNewswire Inc.

Form 4 - Statement of changes in beneficial ownership of securities
Tuesday 14 January 2025 (2 months ago) • Edgar (US Regulatory)

More Eterna Therapeutics Inc News Articles

Northwest Biotherapeutics (QB)

Elite Pharmaceuticals (QB)

Lightwave Logic

Digital Brand Media and ... (PK)

Rennova Health (CE)

Fannie Mae (QB)

Anavex Life Sciences

TPT Global Tech (PK)

Accredited Solutions (PK)

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions